Margareta Radić-Antolić
9:15 am
-
9:30 am
Exhibition Hall
Next Generation Sequencing in AML: to whom, why and when?
Next Generation Sequencing (NGS) has become an essential tool in the diagnosis and management of Acute Myeloid Leukemia (AML). NGS allows for the comprehensive analysis of multiple genes and their mutations simultaneously, providing valuable insights into the genetic landscape of the disease. NGS is typically used for AML patients who have been newly diagnosed, as well as those with relapsed or refractory AML. It can also be applied to patients with high-risk features or those for whom standard treatments have been ineffective...
10:15 am
-
10:30 am
Exhibition Hall
Panel discussion /All speakers
Panel discussion for EET Session 1: Acute myeloid leukemia - Diagnosis & therapy